[ASAP] 1,2,4-Triazine Derivatives as NLRP3 Inhibitors for Treating Diseases

ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00122

Source: ACS Medicinal Chemistry Letters - April 12, 2023 Category: Chemistry Authors: Ram W. Sabnis Source Type: research